Long-term follow-up of children with chronic myeloid leukemia after hematopoietic stem cell transplantation and tyrosine kinase inhibitor therapy

MeSH terms

• Antineoplastic Agents / therapeutic use*
• Follow-Up Studies
• Hematopoietic Stem Cell Transplantation* / adverse effects
• Humans
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / epidemiology
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / mortality
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
• Morbidity
• Mortality
• Protein Kinase Inhibitors / therapeutic use*
• Treatment Outcome